Supply Issues PDI (EMEA) Disinfectant Wipes VJT516 (ICN 3418)

• The supply issue with disinfectant wipes from PDI (EMEA) is now resolved.
• VJT516 is available to order through our online catalogue.
• This ICN is now closed.

• The supply issue with disinfectant wipes from PDI is continuing.
• One product remains suspended and unavailable to order:
  • VJT516 – Wipe disinfectant moist 70% alcohol 2% chlorhexidine gluconate 18gsm 150mm x 133mm box of 100 individual sachets class IIa medical device.
• One product code remains affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is now anticipated to be resolved by 7 December 2026.

Change:

• The supplier PDI (EMEA) has informed us of a supply issue with its disinfectant wipes.
• There is one product code affected:
  • VJT516 – Wipe disinfectant moist 70% alcohol 2% chlorhexidine gluconate 18gsm 150mm x 133mm box of 100 individual sachets class IIa medical device.
• The supply issue is due to raw material shortage, caused by increased cost in polypropylene and isopropyl alcohol.

Impact:

• The affected product is currently suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • VJT614 – Wipe disinfectant moist 70% IPA 2% chlorhexidine 18gsm 195mm x 105mm box of 200 individual sachets class IIa medical device
  • VJT638 – Wipe disinfectant moist 70% alcohol 2% chlorhexidine gluconate 23gsm 190mm x 105mm box of 240 individual sachets class IIa medical device.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 4 September 2026.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.